Balawag, Remwel G.
HRN: 22-41-38 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/27/2023
CLARITHROMYCIN 125MG/5ML, 60ML SUSPENSION (BOT)
12/27/2023
01/03/2024
ORAL
3ml
Bid
PCAP C
Waiting Final Action
Indication: Empirical Escalation Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes